Fluvirin (Seqirus Inc.)


Welcome to the PulseAid listing for the Fluvirin drug offered from Seqirus Inc.. This Inactivated Influenza B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: Seqirus Inc.
NON-PROPRIETARY NAME: A/Singapore/GP1908/2015 IVR-180 (an A/Michigan/45/2015 (H1N1)pdm09-like virus, A/Hong Kong/4801/2014, NYMC X-263B (H3N2) (an A/Hong Kong/4801/2014-like virus), and B/Brisbane/60/2008, wild type (a B/B
SUBSTANCE NAME: INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIR
TYPE: VACCINE
PHARMA CLASS: Inactivated Influenza B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Inactivated [Chemical/Ingredient],Influenza Vaccines [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30


Fluvirin VACCINE Details:

Item DescriptionFluvirin from Seqirus Inc.
LABELER NAME: Seqirus Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 15; 15; 15(ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2017-07-01
END MARKETING DATE: 2018-06-30
PRODUCT ID: 70461-120_b483a28e-2233-4285-b755-267b9f166dc9
PRODUCT NDC: 70461-120
APPLICATION NUMBER: BLA103837

Other INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA A VIRUS A/HONG KONG/4801/2014 X-263B (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED); INFLUENZA B VIR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seqirus Inc.Fluvirin